EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Legend Biotech Corporation Sponsored ADR (LEGN) EBITDA Margin data is not available.
| Income Statement Financials | |
$195.05M |
|
$-100.92M |
|
$71.34M |
|
$123.71M |
|
$300.21M |
|
$-105.16M |
|
$6.03M |
|
$-99.13M |
|
$-98.16M |
|
$-100.92M |
|
$-100.92M |
|
$-100.92M |
|
$-99.96M |
|
$-105.16M |
|
$-99.96M |
|
183.76M |
|
183.76M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$1.22B |
|
$98.81M |
|
$396.86M |
|
$1.62B |
|
$234.37M |
|
$305.75M |
|
$363.53M |
|
$597.90M |
|
$1.02B |
|
$1.02B |
|
$1.02B |
|
184.03M |
|
| Cash Flow Statement Financials | |
$-103.75M |
|
$256.64M |
|
$0.67M |
|
$286.75M |
|
$441.70M |
|
$154.95M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.20 |
|
-- |
|
-- |
|
0.23 |
|
0.36 |
|
63.42% |
|
-53.91% |
|
-53.91% |
|
|
EBITDA Margin |
-- |
-50.82% |
|
-51.74% |
|
$-105.76M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
2.31 |
|
528.60 |
|
0.17 |
|
-9.92% |
|
-9.94% |
|
-6.25% |
|
-7.62% |
|
$5.53 |
|
$-0.58 |
|
$-0.56 |
|